Study #2022-0804
APAL2020SC: Pediatric Acute Leukemia (PedAL) screening trial - developing new therapies for relapsed leukemias
MD Anderson Study Status
Enrolling
Treatment Agent
Description
This study aims to use clinical and biological characteristics of acute leukemias to screen for patient eligibility for available pediatric leukemia sub-trials. Testing bone marrow and blood from patients with leukemia that has come back after treatment or is difficult to treat may provide information about the patient's leukemia that is important when deciding how to best treat it, and may help doctors find better ways to diagnose and treat leukemia in children, adolescents, and young adults.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Acute Lymphoblastic Leukemia;Acute Myeloid Leukemia;Acute Myeloid Leukemia Post Cytotoxic Therapy;Juvenile Myelomonocytic Leukemia;Mixed Phenotype Acute Leukemia;Myelodysplastic Syndrome;Myelodysplastic Syndrome Post Cytotoxic Therapy;Myeloid Leukemia Associated With Down Syndrome
Study phase:
Physician name:
Najat Daw Bitar
Department:
Pediatrics
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.